GH1 gene deletions and IGHD type 1A

Area of Science:

• Genetics
• Endocrinology

Background:

• The Human Growth Hormone gene (GH1) is located on chromosome 17q22-24.
• Growth Hormone Deficiency (GHD) has multiple causes, with a significant genetic component.
• Isolated GHD type IA (IGHD IA) is the most severe autosomal recessive form of GHD.

Purpose of the Study:

• To describe the genetic basis and clinical presentation of IGHD IA.
• To differentiate IGHD IA from other forms of GHD.
• To explore the mechanisms of GH1 gene mutations and antibody formation.

Main Methods:

• Review of genetic and clinical literature on IGHD IA.
• Analysis of GH1 gene mutations (deletions, frameshifts, nonsense mutations).
• Discussion of immune tolerance in heterozygous individuals.

Main Results:

• IGHD IA is characterized by severe dwarfism by six months of age, often with early hypoglycemia.
• Complete absence of GH results from severe loss-of-function GH1 mutations, including deletions, frameshifts, and nonsense mutations.
• GH1 gene deletions are recurring mutations arising from meiotic recombination.
• Anti-GH antibodies can develop after exogenous GH therapy, impacting treatment efficacy.

Conclusions:

• IGHD IA is a severe GHD caused by complete loss of GH function due to severe GH1 mutations.
• Understanding GH1 mutations is crucial for diagnosing and managing GHD.
• Mechanisms of mutation and antibody formation provide insights into GHD pathogenesis and treatment challenges.